Gan & Lee Pharmaceuticals Hits Day Low of CNY 68.89 Amid Price Pressure

Gan & Lee Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 6.44% on October 14, 2025. The stock reached an intraday low of CNY 68.89, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 8.83%, while its performance over the last month shows a decline of 6.68%.
Despite these short-term fluctuations, Gan & Lee Pharmaceuticals has demonstrated strong performance over the past year, with a remarkable increase of 48.21%, significantly outperforming the China Shanghai Composite, which rose by 20.88% during the same period. The company has also shown consistent growth, with a net sales increase of 9.89% reported in its latest results.

Financial metrics indicate a solid market position, with a market capitalization of CNY 38,306 million and a return on equity of 7.85%. The company has maintained positive operating cash flow and has reported a decrease in raw material costs year-over-year. These factors contribute to its standing in the pharmaceuticals and biotechnology industry, despite the recent stock performance.